Top 10 Private Equity Investors: MedicalDevices/Diagnostics
| Rank | Investor Name |
|---|---|
| 1 | Boston Scientific |
| 2 | Stryker Corporation |
| 3 | Accelmed Partners |
| 4 | Balance Point Capital |
| 5 | BioMérieux |
| 6 | Charlesbank Capital Partners |
| 7 | Grand Sud Ouest Capital |
| 8 | Catholic Health Initiatives |
| 9 | Resmed |
| 10 | MVM Partners |
A meaningful share of activity comes through add-on acquisitions, alongside new platform investments. Device investment follows regulatory approvals and strategic acquirer appetite, with strategics active alongside sponsors. These are buyers and control investors. This list is most relevant if you are selling the company, recapitalizing, or seeking a majority partner.
The CapitalDart directory identifies the right person to contact at each of these firms, with their individual investment criteria.
Rankings reflect investment activity from January 2025 through July 2026 in US and Canada companies, based on transactions matched to the CapitalDart directory. Seed and Early Stage rank by participation, Later Stage by rounds led, Private Equity by control and buyout activity. Updated periodically.